Trial Profile
Topical Retinoids and Diabetic Neuropathic Ulceration.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Tretinoin (Primary)
- Indications Diabetic foot ulcer; Diabetic neuropathies; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Jul 2019 Status changed from recruiting to completed.
- 11 Jul 2011 New trial record